Estrella Immunopharma (ESLA) Short Interest Ratio & Short Volume $1.01 +0.03 (+3.06%) Closing price 05/21/2025 04:00 PM EasternExtended Trading$1.02 +0.01 (+1.49%) As of 05/21/2025 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Estrella Immunopharma Short Interest DataEstrella Immunopharma (ESLA) has a short interest of 21,300 shares, representing 0.21% of the float (the number of shares available for trading by the public). This marks a 1,021.05% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 85,838 shares to cover all short positions.Current Short Interest21,300 sharesPrevious Short Interest1,900 sharesChange Vs. Previous Month+1,021.05%Dollar Volume Sold Short$23,004.00Short Interest Ratio0.2 Days to CoverLast Record DateApril 30, 2025Outstanding Shares36,166,000 sharesFloat Size10,100,000 sharesShort Percent of Float0.21%Today's Trading Volume7,341 sharesAverage Trading Volume85,838 sharesToday's Volume Vs. Average9% Short Selling Estrella Immunopharma? Sign up to receive the latest short interest report for Estrella Immunopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartESLA Short Interest Over TimeESLA Days to Cover Over TimeESLA Percentage of Float Shorted Over Time Estrella Immunopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202521,300 shares $23,004.00 +1,021.1%0.2%0.2 $1.08 4/15/20251,900 shares $1,616.90 -88.8%0.0%0 $0.85 3/31/202517,000 shares $15,759.00 -24.8%0.2%0.3 $0.93 3/15/202522,600 shares $20,792.00 +2.7%0.2%0.4 $0.92 2/28/202522,000 shares $22,660.00 +349.0%0.2%0.3 $1.03 2/15/20254,900 shares $5,978.00 -52.9%0.1%0.1 $1.22 1/31/202510,400 shares $10,930.40 -28.3%0.1%0.4 $1.05 1/15/202514,500 shares $16,670.65 +17.9%0.1%0.5 $1.15 12/31/202412,300 shares $14,760.00 -10.9%0.1%0.3 $1.20 12/15/202413,800 shares $16,473.06 -63.4%0.1%0.1 $1.19 Get the Latest News and Ratings for ESLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 11/30/202437,700 shares $42,789.50 +158.2%0.4%0.3 $1.14 11/15/202414,600 shares $12,994.00 +124.6%0.1%0.1 $0.89 10/31/20246,500 shares $5,199.35 -57.0%0.1%0.1 $0.80 10/15/202415,100 shares $12,231.00 -95.6%0.2%0.1 $0.81 9/30/2024346,200 shares $401,592.00 +3,506.3%3.9%1.8 $1.16 9/15/20249,600 shares $10,464.00 -51.3%0.1%0.1 $1.09 8/31/202419,700 shares $24,822.00 -1.5%0.2%0.2 $1.26 8/15/202420,000 shares $28,200.00 -50.0%0.2%0.2 $1.41 7/31/202440,000 shares $62,400.00 +109.4%0.4%0.4 $1.56 7/15/202419,100 shares $28,650.00 +8.5%0.2%1.1 $1.50 6/30/202417,600 shares $18,480.00 +60.0%0.2%1.2 $1.05 6/15/202411,000 shares $10,340.00 +0.9%0.1%0.8 $0.94 5/31/202410,900 shares $10,320.12 +18.5%0.1%0.5 $0.95 5/15/20249,200 shares $9,936.00 -18.6%0.1%0.3 $1.08 4/30/202411,300 shares $11,865.00 +145.7%0.1%0.4 $1.05 4/15/20244,600 shares $4,876.00 -41.8%0.1%0.2 $1.06 3/31/20247,900 shares $9,796.00 +61.2%0.1%0.2 $1.24 3/15/20244,900 shares $5,439.00 -88.1%0.1%0.1 $1.11 2/29/202441,100 shares $41,922.00 -28.0%0.5%1 $1.02 2/15/202457,100 shares $62,239.00 +117.9%0.7%1.2 $1.09 1/31/202426,200 shares $29,344.00 No Change0.3%0.5 $1.12 ESLA Short Interest - Frequently Asked Questions What is Estrella Immunopharma's current short interest? Short interest is the volume of Estrella Immunopharma shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 21,300 shares of ESLA short. 0.21% of Estrella Immunopharma's shares are currently sold short. Learn More on Estrella Immunopharma's current short interest. What is a good short interest percentage for Estrella Immunopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.21% of Estrella Immunopharma's floating shares are currently sold short. Is Estrella Immunopharma's short interest increasing or decreasing? Estrella Immunopharma saw a increase in short interest in April. As of April 30th, there was short interest totaling 21,300 shares, an increase of 1,021.1% from the previous total of 1,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Estrella Immunopharma's float size? Estrella Immunopharma currently has issued a total of 36,166,000 shares. Some of Estrella Immunopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Estrella Immunopharma currently has a public float of 10,100,000 shares. How does Estrella Immunopharma's short interest compare to its competitors? 0.21% of Estrella Immunopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Estrella Immunopharma: Korro Bio, Inc. (19.34%), SELLAS Life Sciences Group, Inc. (7.73%), FitLife Brands, Inc. (0.26%), Nkarta, Inc. (10.58%), Tango Therapeutics, Inc. (21.23%), Eupraxia Pharmaceuticals Inc. (0.50%), Aclaris Therapeutics, Inc. (4.11%), ADC Therapeutics SA (4.51%), Larimar Therapeutics, Inc. (9.32%), Editas Medicine, Inc. (13.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Estrella Immunopharma stock? Short selling ESLA is an investing strategy that aims to generate trading profit from Estrella Immunopharma as its price is falling. ESLA shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Estrella Immunopharma? A short squeeze for Estrella Immunopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ESLA, which in turn drives the price of the stock up even further. How often is Estrella Immunopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ESLA, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Korro Bio Short Interest Data SELLAS Life Sciences Group Short Interest Data FitLife Brands Short Interest Data Nkarta Short Interest Data Tango Therapeutics Short Interest Data Eupraxia Pharmaceuticals Short Interest Data Aclaris Therapeutics Short Interest Data ADC Therapeutics Short Interest Data Larimar Therapeutics Short Interest Data Editas Medicine Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ESLA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.